Impact of Medication Adherence on Virologic Failure in A5202: A Randomized, Partially Blinded, Phase 3B Study.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 28329243.
- Also identified by DOI 10.1093/cid/cix176 and PMC identifier 5434358.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In AIDS Clinical Trials Group A5202, participants who reported missing their medication within the past month or not providing adherence reports at both 8 and 24 weeks had 5 times the hazard of virological failure compared to more adherent participants. Adherence interventions should focus on such patients.
Medical subject headings
- Anti-HIV Agents
- HIV Infections
- Medication Adherence